金吾财讯 | 据港交所12月11日披露，健康之路通过港交所上市聆讯，建银国际为独家保荐人。公司于中国经营数字健康医疗服务平台。根据弗若斯特沙利文的资料，按截至2023年12月31日公司平台上的注册个人用户数目来计算，公司是第四大数字健康医疗服务平台。根据弗若斯特沙利文的资料，按2023年的收入来计算，公司亦是第五大数字健康医疗服务平台，市场份额低于5%。财务方面，公司于2021-2023年及2024年上半年，录得收入4.31亿元、5.69亿元、12.44亿元及6.11亿元人民币，同期对应公司权益股东应占亏损1.57亿元、2.58亿元、3.1亿元及5581.8万元人民币。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.